Ben George, MD
Assistant Professor of Medicine
Dr. Ben George joined the Medical College of Wisconsin faculty in 2011 as an Assistant Professor of Medicine in the Division of Hematology and Oncology. Dr. George specializes in Gastrointestinal Medical Oncology. His interests include colorectal cancer, pancreatic cancer, gastric cancer, esophageal cancer, small bowel and appendiceal neoplasms, cholangiocarcinoma, and hepatocellular carcinoma. His current research interests are focused on colorectal cancer and pancreatic cancer.
Dr. George graduated from Medical College Thiruvananthapuram, in Kerala, India in 1998. He was a PhD candidate in Pathology at the Keck School of Medicine (University of Southern California) in Los Angeles, CA from 1999-2004. In 2005, Dr. George completed an internship in Internal Medicine at the Medical College of Ohio and subsequently his residency at Gunderson Lutheran Medical Center in La Crosse, WI. He then completed a fellowship in Hematology and Oncology at the Medical College of Wisconsin (2007-2010). Most recently, Dr. George completed a dedicated fellowship in Gastrointestinal Medical Oncology at the MD Anderson Cancer Center in Houston, Texas. He is board certified in medical oncology and hematology.
George B, Kopetz S; Predictive and Prognostic Markers in Colorectal Cancer. Current Oncology Reports (in press)
Sukumaran S, George B, Parameshwaran NH, Drobyski WR; Posterior Reversible Encephalopathy Syndrome (PRES) in association with high dose steroids after autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation 45: 779-780, 2010
George B, Wirostko W, Connor T, Choong NW; Complete and Durable Response of Choroid Metastasis from Non-Small Cell Lung Cancer with Systemic Bevacizumab and Chemotherapy. Journal of Thoracic Oncology 4: 661-662, 2009
George B, Datar RH, Wu L, Cai J, Patten N, Beil SJ,Groshen S, Stein J, Skinner D, Jones PA, Cote RJ;p53 Gene and Protein Status:The role of p53 Alterations in Predicting Outcome in Patients with Bladder Cancer. Journal of Clinical Oncology 25 (34):5352-5358, 2007
Mitra AP, Almal AA, George B, Fry DW, Lenehan PF, Pagliarulo V, Cote RJ, Datar RH, Worzel WP;The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. BMC Cancer 6:159, 2006
*Chatterjee SJ, *George B, Shi S-R, Datar RH, Goebell PJ, Fung YK, Jones PA, Cordon-Cardo C, Cote RJ; Hyperphosphorylation of pRB: a mechanism for Rb tumor suppressor pathway inactivation in bladder cancer. Journal of Pathology 203: 762-770, 2004
Pagliarulo V, George B, Beil SJ, Groshen SG, Laird PW, Cai J, Willey JC, Cote RJ, Datar RH; Sensitivity and reproducibility of standardized competitive RT PCR for transcript quantification and its comparison with real-time RT-PCR. Molecular Cancer 3: 5-11, 2004
Chatterjee SJ, Datar RH, Youssefzadeh D, George B, Stein JP, Young L, Shi S-R, Gee C, Groshen SG, Skinner DG, Cote RJ; The combined effects of p53,p21 and pRb expression in the progression of bladder transitional cell carcinoma. Journal of Clinical Oncology 22 (6):1007-1013, 2004
George B, Datar RH, Cote RJ; Molecular biology of bladder cancer : Cell Cycle Alterations. Chapter 10 (pages 107-122), Textbook of Bladder Cancer, Taylor & Francis Ltd, 2006